Ferreira, M.H.Q. et al. 2017. Therapeutic action of the evolocumab monoclonal antibody against PCSK9 proteins in LDL cholesterol modulation: systematic review. Journal of Health Care. 15, 52 (Aug. 2017), 72–77. DOI:https://doi.org/10.13037/ras.vol15n52.4439.